Paediatric Infectious Diseases Clinician Researcher, Research Fellow, Raine Fellow, Deputy Director of the Wesfarmers Centre of Vaccines and Infectious Diseases
MBBS (Hons), FRACP, PhD, DTM&H, DCH
Dr Charlie McLeod is an Infectious Diseases Paediatrician, Year 1 post-doctoral researcher and recent recipient of a RAINE clinical research fellowship (2021-24) with emergent expertise in patient-centred research and novel clinical trial methodology.
Dr McLeod is a Deputy Director at the Wesfarmers Centre of Vaccines and Infectious Diseases, based at Telethon Kids Institute, and of a member of the Centre's Infectious Diseases Implementation Research (IDIR) team. IDIR forms part of the Adaptive Health Intelligence (AHI) collaboration, which includes the Health and Clinical Analytics unit at the University of Sydney. AHI supports the design and implementation of embedded clinical trials using innovative trial methodologies and analytical approaches to create ‘learning health systems’ to simultaneously generate and translate high-quality evidence to inform practice and policy.
Dr McLeod is also an elected representative of the Scientific and Safety Committee at the Child and Adolescent Health Service HREC.
- Projects
-
Publications
March 2023
Patient-reported outcome measures for paediatric acute lower respiratory infection studies
Patient-reported outcome measures (PROMs) are recommended for capturing meaningful outcomes in clinical trials. The use of PROMs for children with acute lower respiratory infections (ALRIs) has not been systematically reported. We aimed to identify and characterise patient-reported outcomes and PROMs used in paediatric ALRI studies and summarise their measurement properties.
Published research Infectious Disease Implementation Research Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Respiratory viral infectionsSeptember 2022Protocol for establishing a core outcome set for evaluation in studies of pulmonary exacerbations in people with cystic fibrosis
Pulmonary exacerbations are associated with increased morbidity and mortality in people with cystic fibrosis (CF). There is no consensus about which outcomes should be evaluated in studies of pulmonary exacerbations or how these outcomes should be measured.
Cystic Fibrosis Published research Infectious Disease Implementation Research Infectious Diseases Epidemiology Subsite: Wesfarmers Centre of Vaccines and Infectious Diseases Subsite: Walyan BREATH -
Education and Qualifications
-
Awards/Honours
-
Active Collaborations
-
Projects